These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10299064)
21. Drug Information Association membership directory, 1974-1975. Drug Inf J; 1975; 9(1):36 pages between p. 26 and p. 27. PubMed ID: 10297120 [No Abstract] [Full Text] [Related]
22. Obtaining drug information from pharmaceutical manufacturers. Schneiweiss F Drug Intell Clin Pharm; 1983 Jan; 17(1):27-32. PubMed ID: 6337799 [No Abstract] [Full Text] [Related]
23. Quality of drug information service provided by pharmaceutical manufacturers. Doyal LE Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090 [No Abstract] [Full Text] [Related]
24. Update and correction on drug-information center directory. Rosenberg JM Am J Hosp Pharm; 1982 Jul; 39(7):1157. PubMed ID: 7051821 [No Abstract] [Full Text] [Related]
25. Regulating manufacturer-affiliated communication in the information age. Schulman KA; Abernethy DR; Rathore SS; Woosley RL Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664 [No Abstract] [Full Text] [Related]
27. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan. Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008 [TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical manufacturer's responses to drug information inquiries. Bainbridge CV; D'Ambrosio GG; Petrick RJ; Weiss EM Am J Hosp Pharm; 1982 Sep; 39(9):1532-4. PubMed ID: 7137196 [No Abstract] [Full Text] [Related]
29. Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration. Kale SA; Barkin RL Compr Ther; 2009; 35(2):68-71. PubMed ID: 19618754 [TBL] [Abstract][Full Text] [Related]
30. Information from drug companies and opinion leaders. Liberati A; Magrini N BMJ; 2003 May; 326(7400):1156-7. PubMed ID: 12775588 [No Abstract] [Full Text] [Related]
31. FDA-USP drug product problem reporting program--an update. Wheatley LS Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797 [No Abstract] [Full Text] [Related]
32. A standard of knowledge for pharmaceutical sales representatives. Bootman JL Manag Care Interface; 2006 Oct; 19(10):13. PubMed ID: 17117593 [No Abstract] [Full Text] [Related]
34. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency. Schultheis LW; Rappaport BA Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189 [No Abstract] [Full Text] [Related]
35. Is drug advertising informing the consumer? Hanlon PM Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141 [No Abstract] [Full Text] [Related]
36. Drug information services at Pfizer labs. Gasperino JL Am J Hosp Pharm; 1990 Sep; 47(9):1998-9. PubMed ID: 2220851 [No Abstract] [Full Text] [Related]
37. Drug information services at the Upjohn Company. Baker RP; Gurwich EL; Depew CC Am J Hosp Pharm; 1990 Sep; 47(9):1999-2001. PubMed ID: 2220852 [No Abstract] [Full Text] [Related]
38. Emergency Medical Services buyers guide. Emerg Med Serv; 1977; 6(6):11-88. PubMed ID: 10297046 [No Abstract] [Full Text] [Related]
39. By the numbers. Top 20 pharmaceutical companies. Mod Healthc; 2003 Aug; 33(33):33. PubMed ID: 12964487 [No Abstract] [Full Text] [Related]